This is the first edition of this guideline.
Purpose and scope
To identify evidence-based options for women (and their relatives) who have a late intrauterine fetal death (IUFD: after 24 completed weeks of pregnancy) of a singleton fetus. To incorporate information on general care before, during and after birth, and care in future pregnancies. The guidance is primarily intended for obstetricians and midwives but might also be useful for women and their partners, general practitioners and commissioners of healthcare.
This guideline does not include the management of multiple pregnancies with a surviving fetus, stillbirth following late fetocide, late delivery of fetus papyraceous or the management of specific medical conditions associated with increased risk of late IUFD. Recommendations about the psychological aspects of late IUFD are focused on the main principles of care to provide a framework of practice for maternity clinicians. The full psychological and social aspects of care have been reviewed by Sands (Stillbirth and neonatal death society). 1 The section on postmortem examination covers clinical aspects required for obstetricians and midwives caring for women who have suffered a stillbirth. More detail can be found in a Joint Report by the Royal College of Obstetricians and Gynaecologists (RCOG) and the Royal College of Pathologists. 
Background
The Perinatal Mortality Surveillance Report (CEMACH) 3 defined stillbirth as 'a baby delivered with no signs of life known to have died after 24 completed weeks of pregnancy'. Intrauterine fetal death refers to babies with no signs of life in utero.
Stillbirth is common, with 1 in 200 babies born dead. 3 This compares with one sudden infant death per 10 000 live births. 3 There were 4037 stillbirths in the UK and Crown Dependencies in 2007, at a rate of 5.2 per 1000 total births. The overall adjusted stillbirth rate was 3.9 per 1000. Rates ranged from 3.1 in Northern Ireland to 4.6 in Scotland. Scotland had a significantly higher stillbirth rate than the other nations. 3 Overall, over onethird of stillbirths are small-for-gestational-age fetuses with half classified as being unexplained. 3, 4 The 8th Annual Report of the Confidential Enquiries into Stillbirths and Deaths in Infancy (CESDI) identified suboptimal care as being evident in half of the pregnancies. 5 The stillbirth rate has remained generally constant since 2000. It has been speculated that rising obesity rates and average maternal age might be behind the lack of improvement; 4 a systematic review identified these as the more prevalent risk factors for stillbirth. Another important purpose of investigation is to assess maternal wellbeing and ensure prompt management of any potentially life-threatening maternal disease. This includes a detailed history of events during pregnancy and clinical examination for pre-eclampsia, chorioamnionitis and placental abruption. There is also a moderate risk of maternal disseminated intravascular coagulation (DIC): 10% within 4 weeks after the date of late IUFD, rising to 30% thereafter. This can be tested for by clotting studies, blood platelet count and fibrinogen measurement. 19 Tests should be repeated twice weekly in women who choose expectant management.
It is important to recognise that there is a distinction between the underlying cause of the death (the disease process), the mode of death (for example asphyxia) and the classification of the death (for example growth restriction). Conventional diagnostic systems fail to identify a specific cause in about half of IUFDs. 3 The proportion of unclassified late IUFDs can be significantly reduced with systems that use customised weight-for-gestational-age charts, 20 such as the relevant condition at death (ReCoDe) system, 21 or systems that capture multiple and/or sequential contributing factors, such as Tulip, Perinatal Society of Australia and New Zealand -Perinatal Death Classification (PSANZ-PDC) or Causes Of Death and Associated Conditions (CODAC). 22 Further research is required to determine the optimal classification method and tools.
An abnormal result might not be linked to the IUFD but rather be simply an incidental finding; for example, factor V Leiden is present in about 5% of the general population and will often be an incidental finding. 23 Comprehensive investigation can be important even though one cause is particularly suspected. With a very obvious cause such as massive abruption, nonlethal fetal malformations might be identified at postmortem that would only have been revealed had the baby lived.
Are there any special recommendations for women with an IUFD who are rhesus D-negative?
Women who are rhesus D (RhD)-negative should be advised to have a Kleihauer test undertaken urgently to detect large feto-maternal haemorrhage (FMH) that might have occurred a few days earlier. Anti-RhD gammaglobulin should be administered as soon as possible after presentation.
If there has been a large FMH, the dose of anti-RhD gammaglobulin should be adjusted upwards and the Kleihauer test should be repeated at 48 hours to ensure the fetal red cells have cleared.
If it is important to know the baby's blood group; if no blood sample can be obtained from the baby or cord, RhD typing should be undertaken using free fetal DNA (ffDNA) from maternal blood taken shortly after birth.
Major FMH is a silent cause of IUFD and a Kleihauer test is recommended for all women to diagnose the cause of death (Table 1 ). In those women who are RhD-negative, the potentially sensitising bleed might have occurred days before the death is recognised, threatening the window for optimal timing of anti-RhD gammaglobulin administration (72 hours). 24 Anti-RhD gammaglobulin provides reduced benefit when given beyond 72 hours, up to 10 days after the sensitising event. [25] [26] [27] Persistent positivity of the Kleihauer is often because the baby's group is also RhD-negative, but might occur with very large RhD-positive FMHs. If it is important to distinguish between the two, the baby's blood group can be typed using conventional serology on cord blood. Typing with ffDNA from maternal blood is also available. In one series of 226 pregnancies with an informative result, fetal RhD status was correctly predicted in 223 women whose babies had not received intrauterine transfusions. In a series of 14 women with pre-eclampsia, one woman with an IUFD had significantly higher levels of ffDNA compared with women with live fetuses. 29 
What tests should be recommended to identify the cause of late IUFD?
Tests should be directed to identify scientifically proven causes of late IUFD.
Commonly associated antepartum conditions include congenital malformation, congenital fetal infection, antepartum haemorrhage, pre-eclampsia and maternal disease such as diabetes mellitus. 3, 4 The common causes of intrapartum death include placental abruption, maternal and fetal infection, cord prolapse, idiopathic hypoxia-acidosis and uterine rupture. 3, 4 Transplacental infections associated with IUFD include cytomegalovirus 30 (Evidence level 2+), syphilis [31] [32] [33] [34] (Evidence level 1+) and parvovirus B19 34, 35 (Evidence level 2++) as well as listeria 36, 37 (Evidence level 2+), rubella 38 (Evidence level 3), toxoplasmosis 33, 34 (Evidence level 2+), herpes simplex 30 (Evidence level 2+), coxsackievirus, leptospira, Q fever, and Lyme disease. 39 Malaria parasitaemia has also been associated with stillbirth (OR 2.3, 95% CI 1.3-4.1) 40 (Evidence level 2++).
Ascending infection, with or without membrane rupture, with Escherichia coli, Klebsiella, Group B Streptococcus, Enterococcus, mycoplasma/ureaplasma, Haemophilus influenzae and Chlamydia are the more common infectious causes in developed countries. [32] [33] [34] 41 Other infections are either historical causes or common only in developing countries.
39 Table 1 42-76 summarises the diagnostic tests available, their indications and value and the evidence to support their use. Some tests should be taken before birth. Tests below the bold line are fetal. Shaded tests are selective. AV = atrioventricular; CMV = cytomegalovirus; CRP = C-reactive protein; DIC = disseminated intravascular coagulation; FT3 = free triiodothyronine; FT4 = free thyroxin index; HbA1c = glycated haemoglobin; IUFD = intrauterine fetal death; IUGR = intrauterine growth restriction; RhD = rhesus D; TSH = thyroid-stimulating hormone doubt, the genetic sex can be tested rapidly on skin (or placental) tissue, even of macerated babies. 77 QF-PCR with additional Y chromosome markers can provide a highly accurate result within two working days in more than 99.9% of samples. 78 Sexing can also be performed rapidly and reliably by FISH.
Ω If these techniques fail, sex can be determined on cell culture or at postmortem, but these methods can take longer.
If the genital sex is not clear and the parents do not wish for postmortem testing in any form, they might wish to judge the sex themselves for registration purposes, perhaps based on an earlier scan, or ask the midwife or doctor to make a judgement. Other parents might choose not to sex the baby and give a neutral name. Stillborn babies can be registered as having indeterminate sex (see section 8.4).
What is best practice guidance for cytogenetic analysis of the baby?
Written consent should be taken for any fetal samples used for karyotyping.
Samples from multiple tissues should be used to increase the chance of culture.
More than one cytogenetic technique should be available to maximise the chance of informative results.
Culture fluid should be stored in a refrigerator and thawed thoroughly before use.
Karyotyping is important as about 6% of stillborn babies will have a chromosomal abnormality. [80] [81] [82] Some abnormalities are potentially recurrent and can be tested for in future pregnancies. Culture potentially provides the greatest range of genetic information (trisomies, monosomies, translocations, major deletions and marker chromosomes). Microdeletions have to be requested specifically, usually according to the result of any postmortem examination. If all cultures fail, QF-PCR can be performed on extracted DNA. 83, 84 Many laboratories are moving towards DNA-based methods for routine chromosome analysis, avoiding the need for cell culture. It is a reliable (<0.01% failure rate), efficient and cheap technique for detecting common aneuploidies. 78 It provides slightly less detailed limited genetic information and is unreliable for the detection of translocations and marker chromosomes.
A range of tissue types can be used (see below), but all cell cultures can fail. 71, 85 Contamination with bacteria is an avoidable reason for failure to obtain results. 78 Culture fluid containing antibiotics can reduce this risk. Perinatal specimens suitable for karyotyping include skin, cartilage and placenta. Skin specimens are associated with a higher rate of culture failure (~60%), twice that of other tissues, including placenta. Placenta usually has the advantages of being the most viable tissue and of more rapid cell culture, but the disadvantages of maternal contamination and placental pseudomosaicism. 86 The next best is cartilage, e.g. patella, but cartilage is harder to sample. 87 Amniocentesis can also provide cytogenetic results if the mother chooses expectant management, 1, 71, 73, 74 but patient acceptability and safety (infection) of amniocentesis has not been investigated in this setting.
Placental biopsy (approximately 1 cm diameter) should be taken from the fetal surface close to the cord insertion (to avoid tissue of maternal origin2). Skin biopsy should be deep to include underlying muscle 2 (about 1 cm in length from the upper fleshy part of the thigh). The skin can be closed with wound adhesive strips and tissue adhesives, but this is less successful when the baby is severely macerated. 
What is the guidance on perinatal postmortem examination for maternity clinicians?
Parents should be offered full postmortem examination to help explain the cause of an IUFD.
Parents should be advised that postmortem examination provides more information than other (less invasive) tests and this can sometimes be crucial to the management of future pregnancy.
Attempts to persuade parents to choose postmortem must be avoided; individual, cultural and religious beliefs must be respected. The examination should be undertaken by a specialist perinatal pathologist.
Written
Parents who decline full postmortem might be offered a limited examination (sparing certain organs), but this is not straightforward and should be discussed with a perinatal pathologist before being offered.
Less invasive methods such as needle biopsies can be offered, but these are much less informative and reliable than conventional postmortem.
Ultrasound and magnetic resonance imaging (MRI)
should not yet be offered as a substitute for conventional postmortem.
MRI can be a useful adjunct to conventional postmortem.
It is essential to offer conventional postmortem examination to all parents but in a way that allows free choice; it is now agreed that the quality of the consent process is paramount and not the rate of uptake.
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The 8th CESDI report recommended that all practitioners who discuss postmortems with parents have a responsibility to understand the process so that consent is fully informed. It was also recommended that the consent form should include sections on the purpose of the postmortem; the extent of the examination; possible organ/tissue retention and purpose; what should happen to tissues/organ after postmorten; and research and education. 
What are the recommendations for timing and mode of birth?
Recommendations about labour and birth should take into account the mother's preferences as well as her medical condition and previous intrapartum history.
Women should be strongly advised to take immediate steps towards delivery if there is sepsis, preeclampsia, placental abruption or membrane rupture, but a more flexible approach can be discussed if these factors are not present.
Well women with intact membranes and no laboratory evidence of DIC should be advised that they are unlikely to come to physical harm if they delay labour for a short period, but they may develop severe medical complications and suffer greater anxiety with prolonged intervals. Women who delay labour for periods longer than 48 hours should be advised to have testing for DIC twice weekly (Table 1) .
If a woman returns home before labour, she should be given a 24-hour contact number for information and support.
Women contemplating prolonged expectant management should be advised that the value of postmortem may be reduced.
Women contemplating prolonged expectant management should be advised that the appearance of the baby may deteriorate.
Vaginal birth is the recommended mode of delivery for most women, but caesarean birth will need to be considered with some.
More than 85% of women with an IUFD labour spontaneously within three weeks of diagnosis. 93, 94 If the woman is physically well, her membranes are intact and there is no evidence of pre-eclampsia, infection or bleeding, the risk of expectant management for 48 hours is low. [93] [94] [95] [96] There is a 10% chance of maternal DIC within 4 weeks from the date of fetal death and an increasing chance thereafter. 19 A Swedish study of 380 women with stillbirth and 379 controls with a live healthy child showed that an interval of 24 hours or more from the diagnosis of death in utero to the start of labour was associated with an increased risk of moderately severe anxiety or worse (OR 4.8, 95% CI 1.5-15.9). 97 Vaginal birth can be achieved within 24 hours of induction of labour for IUFD in about 90% of women. 98 Vaginal birth carries the potential advantages of immediate recovery and quicker return to home. Caesarean birth might occasionally be clinically indicated by virtue of maternal condition. The woman herself might request caesarean section because of previous experiences or a wish to avoid vaginal birth of a dead baby. Vaginal birth was described as emotionally distressing by 47% of 314 women with an intrauterine death compared with just 7% of 322 matched controls. 18 This demands a careful and sensitive discussion and joint decision making. The implications of caesarean delivery for future childbearing should be discussed. 99 
How should labour be induced for a woman with an unscarred uterus?
A combination of mifepristone and a prostaglandin preparation should usually be recommended as the first-line intervention for induction of labour. 
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Misoprostol can be used in preference to prostaglandin E2 because of equivalent safety and efficacy with lower cost but at doses lower than those currently marketed in the UK.
Women should be advised that vaginal misoprostol is as effective as oral therapy but associated with fewer adverse effects.
In a study of a case series of 96 women with a late IUFD, the combination of mifepristone and misoprostol gave an average duration of labour of 8 hours. The addition of mifepristone appeared to reduce the time interval by about 7 hours compared with published regimens not including mifepristone, but there was no other apparent benefit. 98 A single 200 mg dose of mifepristone is appropriate for this indication.
A randomised controlled trial comparing intravenous oxytocin alone with intravaginal misoprostol (a prostaglandin E1 analogue) for induction of labour in women with an IUFD showed that misoprostol was more effective. 100 Two randomised controlled trials comparing prostaglandin E2 with low-dose misoprostol for women with a live fetus found misoprostol to be efficacious in cervical ripening and labour induction. The studies demonstrated a similar maternal safety profile for both groups.
101,102
For third-(and second-) trimester IUFD, a systematic review found that vaginal misoprostol for induction of labour appears equally effective as gemeprost but is much cheaper. 103 The average cost per treatment is also much lower for misoprostol than for prostaglandin E2.
102,104
The use of misoprostol for induction of labour in women with IUFD has been endorsed by NICE. 94 NICE recommended that the choice and dose of vaginal prostaglandins should 'take into account the clinical circumstances, availability of preparations and local protocols'. A review of misoprostol use for late IUFD recommended that the dose should be adjusted according to gestational age (100 micrograms 6-hourly before 26 +6 weeks, 25-50 micrograms 4-hourly at 27 +0 weeks or more, up to 24 hours). 105 Misoprostol use in pregnancy is off-label in the UK, 106 and the doses used in these studies are not currently marketed in Britain. Two phase III trials have recently been completed for lower-dose formulations for induction of labour. 101, 102 The current 200 microgram tablet can be divided in half by pharmacists or dissolved in water and administered as measured aliquots. 107 Two randomised controlled trials compared oral and vaginal misoprostol. In the first, the mean induction to birth interval was shorter with vaginal use by 7.9 hours (P<0.05) and there was a reduced need for oxytocin augmentation. 108 In the other, there was no difference in mean induction to birth interval for gestations of more than 28 weeks. 109 In both studies the systemic adverse effects (diarrhoea, vomiting, shivering and pyrexia) were more common with oral misoprostol.
What is best practice for induction of labour for a woman with a history of lower segment caesarean section (LSCS)?
A discussion of the safety and benefits of induction of labour should be undertaken by a consultant obstetrician.
Mifepristone can be used alone to increase the chance of labour significantly within 72 hours (avoiding the use of prostaglandin). Women with a single lower segment scar should be advised that, in general, induction of labour with prostaglandin is safe but not without risk.
Misoprostol can be safely used for induction of labour in women with a single previous LSCS and an IUFD but with lower doses than those marketed in the UK.
Women with two previous LSCS should be advised that in general the absolute risk of induction of labour with prostaglandin is only a little higher than for women with a single previous LSCS.
Women with more than two LSCS deliveries or atypical scars should be advised that the safety of induction of labour is unknown.
A randomised controlled trial of oral mifepristone alone (200 mg three times a day for 2 days) was compared with placebo in women with an IUFD. Labour occurred within 72 hours in significantly more women in the mifepristone group (63% versus 17%, P<0.001).
110
Use of mifepristone in this context is off-label. 106 Mifepristone 600 mg once daily for 2 days can also be used. 106 A transcervical balloon catheter technique was used to induce labour for a small series of 37 women with a live fetus and an unfavourable cervix who had previously undergone a caesarean section. There were no complications and 79% achieved vaginal birth. 111 In another large retrospective study of women with one previous caesarean section, induction of labour with mechanical methods resulted in uterine rupture rates (5 in 862, 0.58%) that were significantly lower than with prostaglandins (18 in 1130, 1.59%) and similar to spontaneous labour (51 in 9239, 0.55%). 112 Mechanical methods of induction might increase the risk of ascending infection in the presence of IUFD. 113 No studies were found on the safety and effectiveness of induction of labour after IUFD in women with a single caesarean section scar. In general maternity care, the RCOG Green-top Guideline on VBAC recommends that women should be informed that there is a higher risk of uterine rupture with induction of labour with prostaglandins. 114 The more frequent serious risks of induction of labour with VBAC relate to the fetus, however. In the National Institute of Child Health (NICH) study of 17 898 women with a live fetus undergoing VBAC, the maternal morbidity associated with VBAC (including induced and augmented labours) was a higher risk of endometritis (OR 1.62, CI 1.40-1.87), blood transfusion (OR 1.71, CI 1.41-2.08) and scar dehiscence/rupture (0.7%). There was no evidence of an increased rate of hysterectomy or maternal death. Of a subset of 4708 women who had had labour induced, 48 had scar problems (1%). 115 The Society of Obstetricians and Gynaecologists of Canada recommended that misoprostol is contraindicated in women with previous caesarean delivery because of a high rate of uterine rupture. 116 A more recent narrative review of induction of labour for late IUFD concluded that misoprostol can be used safely at lower doses for women with a previous caesarean (25-50 micrograms Misoprostol is off-label for this indication, however, and is not currently marketed in the UK at the doses recommended. These lower doses can be prepared in-house by dissolving a 200 microgram tablet in water. 107 No studies were found on the safety of induction of labour in women with two caesarean births and IUFD. A retrospective cohort database study of 3970 women with a live fetus and two previous LSCS compared outcome with those for 20 175 women who had undergone a single procedure. Thirty percent of labours were induced in both groups. The chance of successful vaginal birth was almost identical (~75%). The chance of major maternal morbidity, including rupture, was higher in the multiple LSCS group, but the absolute risk remained low: 3.23% overall (rupture 1.8%) versus 2.12% overall (rupture 0.9%, adjusted OR 1.61, 95% CI 1.11-2.33). No studies were found into the safety of induction of labour in women with three or more caesarean sections and IUFD. VBAC is not ordinarily recommended for women with three previous caesarean sections, previous uterine rupture or upper segment incisions.
114
In a prospective study of 89 women who attempted VBAC after three or more caesareans, including 29 inductions of labour, there were no cases of uterine rupture or of major maternal morbidity, but the upper 95% confidence interval for zero incidence extends to 4% (calculated by guideline developers).
119
No data were found on the maternal safety of VBAC with an IUFD in the presence of atypical uterine scars.
What are considered suitable facilities for labour?
Women should be advised to labour in an environment that provides appropriate facilities for emergency care according to their individual circumstances.
Maternity units should aim to develop a special labour ward room for well women with an otherwise uncomplicated IUFD that pays special heed to emotional and practical needs without compromising safety. This can include a double bed for her partner or other companion to share, away from the sounds of other women and babies.
Care in labour should given by an experienced midwife.
The physical priorities of women with an IUFD vary greatly according to their individual clinical findings.
What are the recommendations for intrapartum antimicrobial therapy?
Women with sepsis should be treated with intravenous broad-spectrum antibiotic therapy (including antichlamydial agents).
Routine antibiotic prophylaxis should not be used.
Intrapartum antibiotic prophylaxis for women colonised with group B streptococcus is not indicated. 
Infection is a common association of late IUFD and the mother can develop severe sepsis from a wide range of bacteria, including severe systemic chlamydial infection. 120 Regardless of the primary cause of death, the fetus can act as a focus for severe secondary sepsis, including gas-forming clostridial species, which can result in severe DIC. 121, 122 In one study, 3.1% of women with an IUFD developed signs of sepsis during induction of labour. 98 It has been suggested that artificial rupture of membranes may facilitate ascending infection, but no studies were found on this aspect of care. It should be remembered that prostaglandins, given to induce labour, are associated with pyrexia. 123 No studies were found on routine intrapartum antibiotic prophylaxis in this specific circumstance.
No studies were found on the use of antibiotics for the prevention of maternal infection in women with a late IUFD. Intrapartum antibiotic prophylaxis for carriers of group B streptococcus is primarily intended to reduce the risk of neonatal infection. A large prospective study of group B streptococcus carriers in the USA showed that 2.0% of women developed postpartum endometritis. 124 
Are there any special recommendations for pain relief in labour?
Diamorphine should be used in preference to pethidine.
Regional anaesthesia should be available for women with an IUFD.
Assessment for DIC and sepsis should be undertaken before administering regional anaesthesia.
Women should be offered an opportunity to meet with an obstetric anaesthetist.
Analgesia is particularly important for women with an IUFD. A study of 314 women with an IUFD and 322 with a live fetus revealed that labour and delivery were assessed as physically insufferably hard by 17% of the affected women compared with 10% of controls. Analgesia was more frequently used during labour for stillbirth. 18 All usual modalities should be available including regional anaesthesia and patient-controlled anaesthesia. Diamorphine and morphine have greater analgesic qualities and longer duration of action than pethidine. They were rated more highly by labouring women in the National Birthday Study. 125 DIC increases the chance of subdural and epidural haematomata with regional anaesthesia. 126, 127 Maternal sepsis can result in epidural abscess formation.
What are the recommendations for women labouring with a scarred uterus?
Women undergoing VBAC should be closely monitored for features of scar rupture.
Oxytocin augmentation can be used for VBAC, but the decision should be made by a consultant obstetrician.
Fetal heart rate abnormality, usually the most common early sign of scar dehiscence, does not apply in this circumstance. Other clinical features include maternal tachycardia, atypical pain, vaginal bleeding, haematuria on catheter specimen and maternal collapse. 114 No studies were found into the safety and effectiveness of oxytocin augmentation in VBAC with IUFD. Women with previous caesarean section and a live fetus who need augmentation of labour have a 73 The RCOG Green-top Guideline on VBAC recommends that the decision to augment with oxytocin should be discussed with a consultant. 114 
Puerperium

Where should women receive care before returning home?
Women should be cared for in an environment that provides adequate safety according to individual clinical circumstance.
Women with no critical care needs should ideally be able to choose between facilities which provide adequate privacy.
Some women have acute medical problems after birth, e.g. sepsis, pre-eclampsia, etc., with continuing critical care needs. Women without acute medical issues who do not want to return home immediately might wish to receive care within the hospital but away from the maternity unit if such a facility is available.
What are the criteria for thromboprophylaxis?
Women should be routinely assessed for thromboprophylaxis, but IUFD is not a risk factor.
Heparin thromboprophylaxis should be discussed with a haematologist if the woman has DIC.
Established guidelines should be followed for thromboprophylaxis. 129 Given the association of late IUFD with obesity, advanced maternal age, infection and maternal disease, 3, 4, 6, 130, 131 it is likely that many women with an IUFD fall into the moderate-or high-risk categories.
What are the options for suppression of lactation?
Women should be advised that almost one-third of those that choose nonpharmacological measures are troubled by excessive discomfort.
Women should be advised that dopamine agonists successfully suppress lactation in a very high proportion of women and are well tolerated by a very large majority; cabergoline is superior to bromocriptine. Dopamine agonists should not be given to women with hypertension or pre-eclampsia.
Estrogens should not be used to suppress lactation.
Suppression of lactation is of psychological importance for some women following IUFD. Up to one-third of women who use simple measures such as a support brassière, ice packs and analgesics experience severe breast pain. 132 A placebo-controlled randomised controlled trial showed that bromocriptine inhibited lactation in more than 90% of women with few adverse effects. 133 A second randomised controlled trial found bromocriptine to be significantly more effective than breast binders. 134 A double-blind randomised controlled trial of 272 women requesting lactation suppression compared a single dose of cabergoline (1 mg) with bromocriptine (2.5 mg twice daily) for 14 days. The two regimens had very similar effectiveness, but cabergoline was simpler to use and had significantly lower rates of rebound breast activity and adverse events. 
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Dopamine agonists are contraindicated in women with hypertension or pre-eclampsia. 136 They can increase blood pressure and have been associated with intracerebral haemorrhage. 137 Estrogen is of unproven benefit for lactation suppression and it increases thromboembolic risk. 138 
Who should be informed of events?
All key staff responsible for care of the woman during pregnancy and afterwards should be informed of events.
All existing appointments should be cancelled -maternity units should keep a list of likely departments that need to be contacted.
All key staff groups must be informed to ensure cancellation of existing appointments and continuity of follow-up. This includes the community midwives, health visitor, antenatal class coordinator and general practitioner. Other existing carers such as psychiatrists, secondary care specialists and drug workers should also be contacted. It should also include voluntary groups who distribute free items to new mothers, but specific details should not be released to maintain confidentiality. Appointments for antenatal clinics (hospital and community), ultrasound scans and preoperative assessment should be cancelled.
Psychological and social aspects of care
What psychological problems can follow late IUFD?
Carers must be alert to the fact that mothers, partners and children are all at risk of prolonged severe psychological reactions including post-traumatic stress disorder but that their reactions might be very different.
Perinatal death is associated with increased rates of admission owing to postnatal depression. 139 Unresolved normal grief responses can evolve into post-traumatic stress disorder. 140, 141 Women with poor social support are particularly vulnerable. 142 Partners of women with an IUFD can also suffer from severe grief responses, but the prevalence of such psychological disorders in partners is not precisely known. Men demonstrate less guilt, anxiety and depression than women themselves, but they can also develop post-traumatic stress disorder. 143 Discordant grief reactions between partners are more common after IUFD than after neonatal death and this is a risk factor for prolonged and abnormal grief reactions. 144 Parental relationships have a 40% higher risk of dissolving after stillbirth compared with live birth. 145 
What is best practice for use of interventions that might aid psychological recovery?
Carers should be aware of and responsive to possible variations in individual and cultural approaches to death.
Counselling should be offered to all women and their partners.
Other family members, especially existing children and grandparents, should also be considered for counselling.
Debriefing services must not care for women with symptoms of psychiatric disease in isolation.
Parents should be advised about support groups.
RCOG Green-top Guideline No. 55 18 of 33 © Royal College of Obstetricians and Gynaecologists Some parents develop prolonged psychological problems after stillbirth. This appears to be much more likely if professional support is not given, 146 but there is a paucity of evidence from randomised trials that address the benefits and pitfalls of psychological interventions after perinatal death. 147 An interview survey of women after an IUFD found that many wanted their carers to understand and acknowledge the nature of perinatal grief. 148 Guilt is a common emotion but is not necessarily voiced. 149 Carers should carefully seek to identify false assumptions made by parents and communicate these to counsellors.
Other members of the family can also be severely affected by bereavement. A 10-year study of 843 parents who experienced a stillbirth, newborn death or sudden unexpected death in infancy included extended family members; primarily grandparents, but also existing children. The most common response of grandparents was a profound need to protect their own child. The study found that grandparents need information on how they can help their children recover from their loss, how long grief lasts and the differences between men's and women's grief responses. Existing children often felt a need to help the family heal. 150 Their grief responses are influenced by their ability to conceptualise death and their parents' responses. 151 Child-parent relationships can be adversely affected if the parents have great difficulty coping with their loss. Some parents wish to have guidance on how to explain the death to siblings and how to help them mourn.
Some UK maternity units have developed debriefing services for parents who have experienced traumatic events in relation to childbirth. One systematic review analysed eight random-allocation trials. There was no evidence of benefit in six studies and possible evidence of harm in a seventh. The authors emphasised the essential need to differentiate between parents who perceive their experience of childbirth as emotionally traumatic and those who develop symptoms of depression or post-traumatic stress disorder (for whom specific psychiatric treatment might be required). 152 Support groups, such as Sands (Stillbirth and neonatal death society), have been developed to offer help to both partners. In an observational study of 23 women who attended pregnancy loss groups, interviews showed that the primary focus for women was the need to seek recognition and acceptance of their grief. 12 The introduction of bereavement support officers has been shown to improve the management of perinatal loss. 153 
What is the evidence for seeing, holding, naming and mementos?
Carers should avoid persuading parents to have contact with their stillborn baby, but should strongly support such desires when expressed.
Parents who are considering naming their baby should be advised that after registration a name cannot be entered at a later date, nor can it be changed.
If parents do decide to name their baby, carers should use the name, including at follow-up meetings.
Parents should be offered, but not persuaded, to retain artefacts of remembrance. 19 Maternity units should have the facilities for producing photographs, palm and foot prints and locks of hair with presentation frames.
Verbal consent should be sought from the parents and information governance regulations should be complied with for clinical photography.
If the parents do not wish to have mementos, staff should offer to store them securely in the maternal case record for future access.
It should be explained that clothes on a macerated baby might become stained.
Many parents expressly wish to see and hold their baby. 15 A study of 309 women found an overall beneficial effect, in terms of better sleep and less chance of getting a headache, after having a stillborn baby. 154 However, another study showed that practices that actively promoted contact with the stillborn baby are associated with worse outcomes. Women who had held their stillborn baby were more depressed than those who only saw the baby, while those who did not see the baby were least likely to be depressed (39% versus 21% versus 6%, P=0.03). Women who had seen their stillborn baby had greater anxiety (P=0.02) and more symptoms of post-traumatic stress disorder than those who had not (P=0.02), and their next-born babies were more likely to show disorganised attachment behaviour (42% versus 8%, P=0.04).
14 Some parents may wish to name their baby, but others may decide not to do so. Either option is allowable in law, but once the stillbirth has been registered, names cannot be added or changed (Births and Deaths Registration Act 1953; amended by the Still-Birth (Definition) Act 1992). 155 Keeping mementoes has not been associated with adverse outcomes, 14 and qualitative studies have shown that many parents value them highly. 97, 156 
What are the legal requirements for medical certification of stillbirth?
Obstetricians and midwives should be aware of the law related to stillbirth.
The following practice guidance is derived from statute and code of practice.
• Stillbirth must be medically certified by a fully registered doctor or midwife; the doctor or midwife must have been present at the birth or examined the baby after birth. The current law on stillbirth registration is set out in the Births and Deaths Registration Act 1953 (amended by the Still-Birth (Definition) Act 1992). 155 The legal definition of stillbirth is: any child expelled or issued forth from its mother after the 24th week of pregnancy that did not breathe or show any other signs of life.
Legal advisors for the Department of Health and the Office for National Statistics have agreed that a fetus that is expelled after 24 weeks of pregnancy, provided it was no longer alive at the 24th week of pregnancy (this fact being either known or provable from the stage of development reached by the dead fetus), does not fall within P the category of births to be registered as a stillbirth under the above Acts. This interpretation is also accepted by the General Register Office for Scotland and the General Register Office for Northern Ireland. 155 When the gestational age is not known before the birth, with unbooked pregnancies for example, the decision about the status of the birth should be made on the basis of the stage of development of the baby on examination.
The doctor or midwife attending the stillbirth is required to issue a Medical Certificate of Stillbirth that enables the birth to be registered. The cause and sequence of medical events leading to the IUFD should be given in as much detail as possible. Nonspecific terms such as anoxia, prematurity and so on should be avoided. Certification should not be delayed for the results of the postmortem.
The mother (or father if the couple were married at the time of birth) is responsible for registering the stillbirth, normally within 42 days (21 days in Scotland) but with a final limit of 3 months for exceptional circumstances. This responsibility can be delegated to health professionals, including a midwife or doctor present at the birth or a bereavement support officer. The person registering the birth has to be able to provide the following:
• the place and date of birth of the baby The Registrar of Births will meet with the parents in private. The birth is entered onto the Stillbirth Register, which is separate from the standard Register of Births. The parents are then issued with a Certificate of Stillbirth and the documentation for burial or cremation. A certificate for cremation cannot be issued before the registration.
If the couple were not married at the time of the birth, the father's details can be added only if one of the following is fulfilled:
• the mother and father go to the register office and sign the stillbirth register together or • where the father is unable to go to the register office with the mother, the father may make a statutory declaration acknowledging his paternity, which the mother must produce to the Registrar (this form can be obtained from any Registrar of Births) or • where the mother is unable to go to the register office with the father, the mother might make a statutory declaration acknowledging the father's paternity, which the father must produce to the Registrar (this form can be obtained from any Registrar of Births).
If information about the father is not recorded initially, it is possible for the birth to be re-registered to include his details later.
Most local authorities have websites on the registering of stillbirth. There are no fees for registration, but additional certificates do carry a charge (£3.50 per copy as of January 2010).
HM Coroner does not normally have jurisdiction over stillbirth, even if the cause of death is not known, but contact should be made for an apparently fresh stillbirth not attended by a healthcare professional. HM Coroner also has discretion to be involved if the death followed a criminal act such as common assault and can then request for any postmortem to be expedited. Twenty-one stillbirths were referred to HM Coroner Services for England and Wales in 2007 and 13 in 2008. If there is suspicion of actions taken deliberately to cause a stillbirth, the police service should be contacted.
What are the recommendations for spiritual guidance, burial, cremation and remembrance?
Maternity units should have arrangements with elders of all common faiths and nonreligious spiritual organisations as a source of guidance and support for parents.
The legal responsibility for the child's body rests with the parents but can be delegated to hospital services.
Parents should be allowed to choose freely about attendance at a funeral service.
A leaflet about the options should be available.
Maternity units should provide a book of remembrance for parents, relatives and friends.
Carers should offer parents the option of leaving toys, pictures and messages in the coffin.
Parents might wish to seek guidance from a spiritual leader or religious elder. Funeral options including burial and cremation should be discussed with parents, taking into account religious and cultural considerations. Practical issues should be discussed with the parents, at a time and to an extent that suits them.
Having a funeral service for the infant was associated with slower resolution of women's psychological distress in one study. 157 An observational study found that most women appreciate rapid arrangements for the funeral or cremation. 158 Some parents choose to leave messages, toys and photographs in the coffin.
If the parents request cremation they have to complete Cremation Form 3 (application for cremation of remains of a stillborn child). Together with a copy of the Stillbirth Certificate (known also as Cremation Form 9), they submit CF3 to the Medical Referee, who issues Cremation Form 10 (authorisation to cremate a stillborn child). Cremation Form 2 is the equivalent of CF3 for retained body parts of a stillborn child when the body has already been cremated.
What advice should be given about fertility?
Information about fertility and contraception should be offered to mothers before returning home.
Mothers are vulnerable to psychological disorders when conception occurs soon after the loss. 141, 143 With suppression of lactation, ovulation returns more quickly. This can be as early as day 18.
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Some women might not be aware that they might conceive before their first menstrual period.
Follow-up
What are the options for follow-up meetings?
The wishes of the woman and her partner should be considered when arranging follow-up.
Before the visit, it is essential to ensure that all available results are readily to hand.
There is no evidence to support home visits over clinic follow-up, or to indicate the optimum timing and frequency of such appointments, but it is recognised that some parents find it very distressing to return to the unit where their baby was stillborn. If practicable, the option of home visits should be offered to parents. Office consultation has the potential advantages over clinic follow-up of preventing waits and allowing flexible duration. Six to eight weeks is common practice for the timing of the appointment, when the placental and the postmortem histology results usually become available, but a flexible approach is appropriate according to the needs of the parents and the range of tests performed. Women should be offered general prepregnancy advice, including support for smoking cessation.
Women should be advised to avoid weight gain if they are already overweight (body mass index over 25) and to consider weight loss.
An offer should be made to discuss the potential benefit of delaying conception until severe psychological issues have been resolved.
Carers should be aware that while mothers tend to experience greater anxiety when conception occurs soon after a fetal loss, partners are more likely to suffer anxiety if conception is delayed.
Parents can be advised that the absolute chance of adverse events with a pregnancy interval less than 6 months remains low and is unlikely to be significantly increased compared with conceiving later.
The meeting should be documented for the parents in a letter that includes an agreed outline plan for future pregnancy.
Women might wish to keep a written log of questions and comments. Some women/couples might wish to use this to help set the agenda themselves at the start of the meeting. As well as an opportunity to ask about the physical and emotional wellbeing of the mother and her partner, the meeting allows parents time to discuss the results of tests and the likely cause of late IUFD. The meeting can also focus on the prognosis and options for future pregnancies. The discussion should cover general preparation for pregnancy: lifestyle, folic acid supplementation and rubella vaccination. Parents often desire an open, honest discussion with an opportunity to make comments and the chance to raise any concerns they might have. If care has been suboptimal, parents might want this to be acknowledged, lessons to be learned and care in the future to be improved.
Vulnerability to depression and anxiety in the next pregnancy is related to time since stillbirth, with more recently bereaved women at significantly greater risk than controls. 160 In contrast to mothers' vulnerability to psychological disorder when conception occurs soon after the loss, fathers tend to experience greater problems when pregnancy is delayed. 161 Two medium-sized studies focusing on women with previous stillbirth have not shown any association between inter-pregnancy interval and pregnancy outcome. 162, 163 Recent larger studies and a meta-analysis 164, 165 of the general maternity population suggested that there is a higher rate of adverse events with shorter inter-pregnancy intervals but the absolute risk remained low. Inter-pregnancy intervals shorter than 6 months were associated with increased risks of preterm birth, low birth weight and small-for-gestational-age babies ( 164 The odds ratio for stillbirth for women who smoke is 1.6 (95% CI 1.2-2.3). Women who stop smoking have equivalent stillbirth rates to women who have never smoked. 166 In two large studies, the odds ratio for stillbirth for women with a prepregnancy body mass index (BMI) over 30 kg/m² ranged from 1.4 to 2.6 (Evidence level 2+) 131, 167 and in a systematic review it was 2.1-2.8. The history of stillbirth should be clearly marked in the case record and carers should ensure they read all the notes thoroughly before seeing the woman.
Women with a previous unexplained IUFD should be recommended to have obstetric antenatal care.
Women with a previous unexplained IUFD should be recommended to have screening for gestational diabetes.
For women in whom a normally formed stillborn baby had shown evidence of being small for gestational age, serial assessment of growth by ultrasound biometry should be recommended in subsequent pregnancies.
Small studies 169 have shown no difference in stillbirth recurrence, but a large retrospective study of 947 women and 261 384 controls showed that women with a history of stillbirth (but otherwise low-risk) had a 12-fold increased risk of intrapartum stillbirth (95% CI 4.5-33.7). 170 A study that compared outcomes in the second pregnancy for 364 women with previous stillbirth versus 33 715 with previous live birth showed an increased risk of pre-eclampsia (OR 3.1, 95% CI 1.7-5.7) and placental abruption (OR 9.4, 95% CI 4.5-19.7).
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Another study of 71 315 women showed that there was an increased risk of ischaemic placental disease (OR 1.6, 95% CI 1.2-2.1), fetal distress (OR 2.8, 95% CI 1.7-4.5), chorioamnionitis (OR 2.3, 95% CI 1.5-4.3), extreme preterm birth (OR 4.2, 95% CI 1.8-9.9) and early neonatal mortality (OR 8.3, 95% CI 3.7-18.6) in pregnancies after stillbirth versus pregnancies after live birth. 162 The increased risk was independent of recurrent maternal conditions and fetal congenital anomalies. 172 An observational study of 316 consecutive pregnancies in women with a history of unexplained stillbirth revealed a rate of gestational diabetes four times higher than expected.
173 A significant proportion of unexplained IUFDs are reclassified as fetal growth restriction when customised charts and different classification systems are used. 20, 21 There are no prospective outcome studies of serial sonography in the next pregnancy after an IUFD, but it is a prudent action that can provide reassurance to most women and partners. The optimum timing and frequency of scans are not known.
What recommendations should be made for the management of future delivery after unexplained stillbirth?
Previous unexplained IUFD is an indication to recommend birth at a specialist maternity unit.
Previous IUFD related to a known nonrecurrent cause merits individual assessment for place of birth. 170 There have been no studies that adequately tested fetal benefit from intervention by routine induction of labour. A study of intrapartum events in 364 pregnancies following unexplained stillbirth has shown higher rates for induction of labour (OR 3.2, 95% CI 2.4-4.2). This was associated with higher rates of instrumental delivery (OR 2.0, 95% CI 1.4-3.0) and emergency caesarean deliveries (OR 2.1, 95% CI 1.5-3.0) compared with controls. 171 Others have shown similar findings.
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These complications were probably iatrogenic, the result of obstetric intervention. 174 
What recommendations should be made for maternal care after the next birth?
Carers should be vigilant for postpartum depression in women with a previous IUFD.
Carers should be aware that maternal bonding can be adversely affected.
The birth of a healthy baby does not compensate for a previous loss and can trigger a resurgence of grief; women might feel happy one moment and sad the next. Depression in the third trimester is highly predictive of depression one year after subsequent birth, particularly for women who conceive within less than 12 months from an IUFD. 160 Unresolved maternal grief may result in disorganisation of attachment with future babies. 
Clinical governance
Are there any risk management standards for IUFD?
Maternity units should be aware of specific standards for IUFD and stillbirth.
National Health Service Litigation Authority risk management maternity standards include expectations for care specific to intrauterine death and stillbirth. These vary from edition to edition.
What are the standards for documentation?
Standardised checklists can be used to ensure that all appropriate care options are offered and that the response to each is recorded.
Consent for perinatal postmortem examination should be documented using the nationally recommended form.
All stillbirths should be reviewed in a multiprofessional meeting using a standardised approach to analysis for substandard care and means of future prevention. Results of the discussion should be recorded in the mother's case record and discussed with the parents.
All stillbirths should be reported to the Centre for Maternal and Child Enquiries (CMACE).
Information leaflets
All women (and partners) should be offered leaflets that provide information on the following issues: 
What is best practice for care of staff?
A system should be in place to give clinical and psychological support for staff involved with an IUFD.
Occupational Health should be contacted for advice if there are particular concerns about fitness to work.
In a survey of 804 doctors' experiences and attitudes in dealing with perinatal death, 75% of respondents reported that caring for a patient with a stillbirth took a large emotional toll on them personally. Nearly one in ten obstetricians reported they had considered giving up obstetric practice because of the emotional difficulty in caring for a woman with a stillbirth. Talking informally with colleagues (87%) or friends/family (56%) had been the most common strategies used by doctors to cope. Confidentiality is important. Improved bereavement training can help staff care for grieving families but can also help staff cope with their own emotions. 176 
What are important auditable standards?
• Proportion of stillbirths reported as a clinical incident (requirement for the Clinical Negligence Scheme for Trusts).
• Completion of investigations for the cause of late IUFD.
• Proportion of parents offered postmortem examination.
• Proportion of parents declining full postmortem who were offered alternative tests.
• Proportion of parents who have postmortem consent undertaken by an appropriately trained obstetrician or midwife.
• Proportion of women offered suppression of lactation.
• Proportion of women given fertility and contraceptive advice.
• Proportion of parents offered follow-up with a senior obstetrician.
• Proportion of women and families offered counselling follow-up.
What are the important aspects of training?
• Seminars on the causes and care of late IUFD.
• Skills training for the ultrasound diagnosis of late IUFD.
• Training for discussions with parents about late IUFD.
• Training on the postmortem examination, including consent.
• Additional training in IUFD for bereavement counsellors.
• Quarterly multidisciplinary clinic-pathology meetings for critical analysis of stillbirths.
• Role play of follow-up appointments for obstetric trainees.
Future research
What are the recommendations for future research?
• The optimal system for classification of stillbirth.
• Safety and efficacy of methods for induction of labour with a previous caesarean section.
• The optimal dose of misoprostol for induction of labour according to gestational age.
• The diagnostic power and accuracy of MRI for postmortem investigation.
• The optimal psychological care of women and their partners.
• A comparison of hospital and home follow-up appointments. 
